Form 4 · Filed Jul 22, 2026, 08:55 PM UTC
PBLS/Parabilis Medicines, Inc.
RA CAPITAL MANAGEMENT, L.P. — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
6 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 22, 2026 | P | buy | 47,250 | $30 | $1,406,633 | 26,529,686 |
| Jul 21, 2026 | P | buy | 21,696 | $28 | $606,620 | 26,438,209 |
| Jul 21, 2026 | P | buy | 6,504 | $29 | $189,722 | 26,444,713 |
| Jul 21, 2026 | P | buy | 37,723 | $30 | $1,131,690 | 26,482,436 |
| Jul 20, 2026 | P | buy | 98,433 | $27 | $2,670,487 | 26,383,526 |
| Jul 20, 2026 | P | buy | 32,987 | $28 | $914,400 | 26,416,513 |
Source: SEC EDGAR raw filing ↗ · Accession 0001231919-26-000779